Boyds

Boyds: A Global Consultancy for Cutting-Edge Medicinal Product Development

Boyds is a global consultancy that specializes in supporting the development of cutting-edge medicinal products and treatments for patient benefit. With over 20 years of experience in the industry, Boyds has established itself as a trusted partner to pharmaceutical and biotech companies around the world.

At Boyds, we understand that developing new medicines and treatments is a complex process that requires expertise across multiple disciplines. That's why we offer a range of services designed to support our clients at every stage of their product development journey.

Our team includes experts in regulatory affairs, clinical development, pharmacovigilance, medical writing, and more. We work closely with our clients to understand their specific needs and develop customized solutions that meet their unique requirements.

One of the key areas where Boyds excels is in regulatory affairs. Our team has extensive experience navigating the complex regulatory landscape across multiple jurisdictions. We can help our clients prepare for meetings with regulators, submit applications for marketing authorization, and manage post-approval activities such as variations or renewals.

In addition to regulatory affairs support, Boyds also offers clinical development services. Our team can help design clinical trials that are scientifically rigorous while also being practical to implement. We have experience working on trials across a range of therapeutic areas including oncology, rare diseases, neurology, and more.

Another area where Boyds stands out is in pharmacovigilance. Our team can help our clients establish robust safety monitoring systems that comply with all relevant regulations while also being efficient and effective at identifying potential safety issues early on.

Finally, we offer medical writing services to support our clients' communication needs throughout the product development process. This includes everything from preparing scientific manuscripts for publication to developing patient information leaflets or other materials aimed at communicating important information about new medicines or treatments.

Overall, Boyds is committed to supporting its clients' efforts to develop new medicines and treatments that can improve patient outcomes. With our deep expertise across multiple disciplines, we are well-positioned to help our clients navigate the complex regulatory landscape and bring their products to market successfully.